Who owns LIMINATUS PHARMA LLC?
- Ticker: LIMNW
- CUSIP Number: 53271x116
Tip: Access positions for across all investors
Analyze quarterly positions in Liminatus Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Liminatus Pharma stock
Who bought or sold LIMINATUS PHARMA LLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Aristeia Capital | 320k | $16k | 0% | Jun 2026 |
|
| Linden Advisors | 268k | $14k | 0% | Jun 2026 |
|
| Saba Capital Management | 234k | $12k | 0% | Jun 2026 |
|
| Moore Capital Management | 125k | $9.4k | 0% | Jun 2026 |
|
| Polar Securities | 123k | $6.3k | 0% | Jun 2026 |
|
| MMCAP International Inc. SPC | 112k | $8.4k | 0% | Jun 2026 |
|
| D. E. Shaw & Co | 83k | $2.9k | 0% | Jun 2026 |
|
| Millennium Management | 71k | $5.3k | 0% | Jun 2026 |
|
| Blue Owl Capital Holdings | 50k | $2.0k | 0% | Jun 2026 |
|
| Toronto-Dominion Bank | 35k | $2.6k | 0% | Jun 2026 |
|
| Periscope Capital | 30k | $2.0k | -37% | Jun 2026 |
|
| LMR Partners | 30k | $2.2k | 0% | Jun 2026 |
|
| Arena Capital Advisors, LLC- CA | 29k | $2.2k | 0% | Jun 2026 |
|
| Jane Street | 24k | $1.8k | 0% | Jun 2026 |
|
| Limestone Investment Advisors | 23k | $1.7k | 0% | Jun 2026 |
|
| Gts Securities | 21k | $1.6k | 0% | Jun 2026 |
|
| Susquehanna International | 18k | $1.3k | 100% | Jun 2026 |
|
| Wolverine Asset Management | 14k | $1.0k | -65% | Jun 2026 |
|
| Flow Traders US | 13k | $1.0k | 0% | Jun 2026 |
|
| Virtu Financial | 11k | $999.462500 | 100% | Jun 2026 |
|
| DuPont Capital Management Corporation | 6.3k | $318.125000 | 0% | Jun 2026 |
|
| UBS Group | 4.5k | $338.025000 | 0% | Jun 2026 |
|
| HGC Investment Management | 1.3k | $94.000000 | 0% | Jun 2026 |
|
Who sold out of Liminatus Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Highbridge Capital Management | Dec 2025 | 159k | $5.5k |